What is NDC 71610-268?

71610-268 is the product NDC for verapamil hydrochloride, Verapamil hydrochloride 240 mg/1 tablet, film coated, extended release, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for verapamil hydrochloride?

131 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

verapamil hydrochloride NDC 71610-268

NDC codes

FDA NDC Directory

Product NDC (as listed)71610-268Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71610-0268Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71610-268-60	7161002686071610026860	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-268-60)Marketed from May 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): verapamil hydrochloride
Generic name (nonproprietary): verapamil hydrochloride
Active ingredients: Verapamil hydrochloride — 240 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078906
Marketing start: Sep 17, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 71610-268_5dfba728-4417-4a75-b194-87feff97aa7bSPL ID 5dfba728-4417-4a75-b194-87feff97aa7bSPL set ID c635f442-2349-4820-877a-a42e5f0a44b5RxCUI 897649UNII V3888OEY5R
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471610026860 followed by a unit qualifier and the quantity

Package 71610-0268-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 8, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Verapamil hydrochloride extended-release tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than o…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71610-268

What is NDC 71610-268?: 71610-268 is the product NDC for verapamil hydrochloride, Verapamil hydrochloride 240 mg/1 tablet, film coated, extended release, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: verapamil hydrochloride.
What is the active ingredient?: Verapamil hydrochloride.
Who is the labeler?: Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for verapamil hydrochloride?: 131 other product NDCs are listed under this name. See all verapamil hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other verapamil hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Verapamil hydrochloride	Verapamil hydrochloride 120 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1953	70771-1953-0170771-1953-05
Verapamil hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1954	70771-1954-0170771-1954-05
Verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1955	70771-1955-0170771-1955-05
Verapamil hydrochloride	Verapamil hydrochloride 120 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-561	68382-0561-0168382-0561-05
Verapamil hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-562	68382-0562-0168382-0562-05
Verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-563	68382-0563-0168382-0563-05
Verapamil Hydrochloride	Verapamil hydrochloride 120 mg/1	Capsule, Extended releaseOral	Safecor Health LLC	48433-145	48433-0145-20
Verapamil Hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	REMEDYREPACK INC.	70518-4513	70518-4513-00
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	REMEDYREPACK INC.	70518-4453	70518-4453-00
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-114	65145-0114-05

All 132 verapamil hydrochloride NDCs

Other NDCs under ANDA 078906

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078906
Product	Strength	Form · route	Labeler	Product NDC
verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-956
verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	PD-Rx Pharmaceuticals, Inc.	55289-723
verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	NuCare Pharmaceuticals, Inc.	66267-212
verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-260
Verapamil Hydrochloride	Verapamil hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals, Inc.	68788-9790
verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	REMEDYREPACK INC.	70518-1326
verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	71205-017